» Articles » PMID: 17576935

Pemphigus Variant Associated with Penicillin Use: a Case-cohort Study of 363 Patients from Israel

Overview
Journal Arch Dermatol
Specialty Dermatology
Date 2007 Jun 20
PMID 17576935
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether medication use is associated with the development of a pemphigus variant.

Design: Population-based case-cohort study.

Setting: Health maintenance organization in Israel.

Methods: All incident pemphigus variant cases diagnosed from January 1, 1997, through December 31, 2001, among 1.5 million members were identified. A cohort of 150,000 was randomly selected from the health maintenance organization population as the control group. Data on case patients and control subjects, including all medication purchased during the 6 months before the diagnosis, were obtained using the health maintenance organization's central database.

Results: We identified a total of 363 case patients diagnosed as having pemphigus during the 5-year study (6,961,853 person-years of follow-up). The mean age at diagnosis was 49.8 (SD, 22.7) years, and 53% of the cases were women. Results of a multivariate analysis showed that increased risk for pemphigus was associated with purchasing penicillin during the 6 months before the diagnosis (odds ratio, 2.03; 95% confidence interval, 1.56-2.64). Compared with individuals with no penicillin purchases, we calculated increased risks of 1.84 (95% CI, 1.36-2.49) and 3.02 (95% CI, 1.41-6.49) in those with 1 and 3 or more purchases, respectively. None of the other examined medications, including cephalosporins, angiotensin-converting enzyme inhibitors, dipyrone, anticonvulsants, and nonsteroidal anti-inflammatory drugs, showed similar risks.

Conclusions: To our knowledge, the present research is one of the largest published epidemiological studies on pemphigus variant. The use of computerized medical and administrative databases allowed the detection of case patients in the community, resulting in a higher calculated incidence rate than previously reported. The findings suggest a relationship between the use of penicillin and pemphigus variant. Further studies to assess the nature of this statistical association are warranted.

Citing Articles

Pemphigus: trigger and predisposing factors.

Moro F, Sinagra J, Salemme A, Fania L, Mariotti F, Pira A Front Med (Lausanne). 2024; 10:1326359.

PMID: 38213911 PMC: 10783816. DOI: 10.3389/fmed.2023.1326359.


The multifactorial complexities of autoimmune development in Pemphigus vulgaris: Critical evaluation of the role of environmental and lifestyle "exposome" factors.

Adebiyi O, Galloway D, Augustin M, Sinha A Front Immunol. 2023; 13:1058759.

PMID: 36703956 PMC: 9871583. DOI: 10.3389/fimmu.2022.1058759.


Clinical and histological characterization of oral pemphigus lesions in patients with skin diseases: a cross sectional study from Sudan.

Suliman N, Astrom A, Ali R, Salman H, Johannessen A BMC Oral Health. 2013; 13:66.

PMID: 24261459 PMC: 3871015. DOI: 10.1186/1472-6831-13-66.


Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.

Aagaard L, Hansen E BMC Clin Pharmacol. 2009; 9:4.

PMID: 19254390 PMC: 2656469. DOI: 10.1186/1472-6904-9-4.